Medical Xpress news
Medical Xpress / Neuroscientists devise formulas to measure multilingualism
More than half of the world's population speaks more than one language—but there is no consistent method for defining "bilingual" or "multilingual." This makes it difficult to accurately assess proficiency across multiple ...
Medical Xpress / Medications may help the aging brain cope with surgery and memory impairment
Simple pharmaceutical interventions could help older brains cope with memory impairment and recovery after surgery, new studies in mice suggest.
Medical Xpress / Molecular mechanism reveals how viral infection triggers aggressive leukemia
Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia virus type I (HTLV-1) drives the development of adult T-cell leukemia-lymphoma (ATL), one of the most ...
Medical Xpress / Back pain is linked to worse sleep years later in men over 65
About half of older men suffer from sleep problems, back pain or both, according to Soomi Lee, associate professor of human development and family studies at Penn State. Lee recently led a study to investigate whether one ...
Medical Xpress / GLP-1 drugs might help quell sleep apnea, study suggests
A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new study says.
Medical Xpress / 'Forever chemicals' common in cosmetics, but FDA says safety data are scant
Federal regulators have released a mandated report regarding the presence of "forever chemicals" in makeup and skincare products.
Medical Xpress / Tangled scar tissue may set stage for dangerous placenta condition
Placenta accreta spectrum (PAS) used to be a rare pregnancy condition, but it now affects roughly 14,000 pregnancies annually, posing a major cause of maternal death. Yet why it happens is still not well understood. Placenta ...
Medical Xpress / High-dose risankizumab trial tests staying power against psoriasis
Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that paired higher-than-approved doses of risankizumab with extended follow-up and found high early skin clearance ...
Medical Xpress / Creating cells that help the brain keep its cool
Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain's support cells into parvalbumin-positive cells. These cells act as the brain's rapid-braking system and are significantly ...
Medical Xpress / Potential biomarker linked to multiple sclerosis progression and brain inflammation
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
Medical Xpress / Tumor bacteria linked to immunotherapy resistance in head and neck cancer
Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others.
Medical Xpress / AI model predicts B cell reactivity to neoantigens for improved cancer vaccines
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move beyond one-time attacks and short-term memory to become a long-term immunity that "remembers" cancer, ...
